127 related articles for article (PubMed ID: 27967239)
41. Preclinical evaluation of zoledronate using an in vitro mimetic cellular model for breast cancer metastatic bone disease.
Dedes PG; Kanakis I; Gialeli Ch; Theocharis AD; Tsegenidis T; Kletsas D; Tzanakakis GN; Karamanos NK
Biochim Biophys Acta; 2013 Jun; 1830(6):3625-34. PubMed ID: 23395844
[TBL] [Abstract][Full Text] [Related]
42. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice.
Sasaki A; Boyce BF; Story B; Wright KR; Chapman M; Boyce R; Mundy GR; Yoneda T
Cancer Res; 1995 Aug; 55(16):3551-7. PubMed ID: 7627963
[TBL] [Abstract][Full Text] [Related]
43. Gene expression of transforming growth factor-beta 1 and its type II receptor in giant cell tumors of bone. Possible involvement in osteoclast-like cell migration.
Zheng MH; Fan Y; Wysocki SJ; Lau AT; Robertson T; Beilharz M; Wood DJ; Papadimitriou JM
Am J Pathol; 1994 Nov; 145(5):1095-104. PubMed ID: 7977641
[TBL] [Abstract][Full Text] [Related]
44. The cellular actions of interleukin-11 on bone resorption in vitro.
Hill PA; Tumber A; Papaioannou S; Meikle MC
Endocrinology; 1998 Apr; 139(4):1564-72. PubMed ID: 9528935
[TBL] [Abstract][Full Text] [Related]
45. ITGBL1 Is a Runx2 Transcriptional Target and Promotes Breast Cancer Bone Metastasis by Activating the TGFβ Signaling Pathway.
Li XQ; Du X; Li DM; Kong PZ; Sun Y; Liu PF; Wang QS; Feng YM
Cancer Res; 2015 Aug; 75(16):3302-13. PubMed ID: 26060017
[TBL] [Abstract][Full Text] [Related]
46. Ipriflavone inhibits osteolytic bone metastasis of human breast cancer cells in a nude mouse model.
Iwasaki T; Mukai M; Tsujimura T; Tatsuta M; Nakamura H; Terada N; Akedo H
Int J Cancer; 2002 Aug; 100(4):381-7. PubMed ID: 12115517
[TBL] [Abstract][Full Text] [Related]
47. Calcium Homeostasis: A Potential Vicious Cycle of Bone Metastasis in Breast Cancers.
Yang Z; Yue Z; Ma X; Xu Z
Front Oncol; 2020; 10():293. PubMed ID: 32211326
[TBL] [Abstract][Full Text] [Related]
48. A metastasis-on-a-chip approach to explore the sympathetic modulation of breast cancer bone metastasis.
Conceição F; Sousa DM; Loessberg-Zahl J; Vollertsen AR; Neto E; Søe K; Paredes J; Leferink A; Lamghari M
Mater Today Bio; 2022 Jan; 13():100219. PubMed ID: 35243294
[TBL] [Abstract][Full Text] [Related]
49. Blocking the impact of chronic stress on bone metastasis.
Bonekey Rep; 2012; 1():190. PubMed ID: 24009980
[No Abstract] [Full Text] [Related]
50. Osteoblasts Are the Centerpiece of the Metastatic Bone Microenvironment.
Jeong HM; Cho SW; Park SI
Endocrinol Metab (Seoul); 2016 Dec; 31(4):485-492. PubMed ID: 28029019
[TBL] [Abstract][Full Text] [Related]
51. Osteoclasts Control Lipid Secretion to Regulate Breast Cancer Bone Metastasis.
Delgado-Calle J
Endocrinology; 2017 Mar; 158(3):458-460. PubMed ID: 28430916
[No Abstract] [Full Text] [Related]
52. Caspase-1 cleaves PPARγ for potentiating the pro-tumor action of TAMs.
Niu Z; Shi Q; Zhang W; Shu Y; Yang N; Chen B; Wang Q; Zhao X; Chen J; Cheng N; Feng X; Hua Z; Ji J; Shen P
Nat Commun; 2017 Oct; 8(1):766. PubMed ID: 28974683
[TBL] [Abstract][Full Text] [Related]
53. Mechanism of ferroptosis in breast cancer and research progress of natural compounds regulating ferroptosis.
Ge A; He Q; Zhao D; Li Y; Chen J; Deng Y; Xiang W; Fan H; Wu S; Li Y; Liu L; Wang Y
J Cell Mol Med; 2024 Jan; 28(1):e18044. PubMed ID: 38140764
[TBL] [Abstract][Full Text] [Related]
54. Metabolic crosstalk between stromal and malignant cells in the bone marrow niche.
Tirado HA; Balasundaram N; Laaouimir L; Erdem A; van Gastel N
Bone Rep; 2023 Jun; 18():101669. PubMed ID: 36909665
[TBL] [Abstract][Full Text] [Related]
55. IL-20RB mediates tumoral response to osteoclastic niches and promotes bone metastasis of lung cancer.
He Y; Luo W; Liu Y; Wang Y; Ma C; Wu Q; Tian P; He D; Jia Z; Lv X; Ma YS; Yang H; Xu K; Zhang X; Xiao Y; Zhang P; Liang Y; Fu D; Yao F; Hu G
J Clin Invest; 2022 Oct; 132(20):. PubMed ID: 36006737
[TBL] [Abstract][Full Text] [Related]
56. Lipids in cancer: a global view of the contribution of lipid pathways to metastatic formation and treatment resistance.
Vasseur S; Guillaumond F
Oncogenesis; 2022 Aug; 11(1):46. PubMed ID: 35945203
[TBL] [Abstract][Full Text] [Related]
57. Yoda1 Enhanced Low-Magnitude High-Frequency Vibration on Osteocytes in Regulation of MDA-MB-231 Breast Cancer Cell Migration.
Lin CY; Song X; Ke Y; Raha A; Wu Y; Wasi M; Wang L; Geng F; You L
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884459
[TBL] [Abstract][Full Text] [Related]
58. Bone-on-a-chip: microfluidic technologies and microphysiologic models of bone tissue.
Mansoorifar A; Gordon R; Bergan R; Bertassoni LE
Adv Funct Mater; 2021 Feb; 31(6):. PubMed ID: 35422682
[TBL] [Abstract][Full Text] [Related]
59. Targeting the Wnt signaling pathway for breast cancer bone metastasis therapy.
Cui J; Chen H; Zhang K; Li X
J Mol Med (Berl); 2022 Mar; 100(3):373-384. PubMed ID: 34821953
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
